Skip to main content
Top
Published in: Nutrition & Metabolism 1/2012

Open Access 01-12-2012 | Research

A 21-day Daniel fast with or without krill oil supplementation improves anthropometric parameters and the cardiometabolic profile in men and women

Authors: John F Trepanowski, Mohammad M Kabir, Rick J Alleman Jr, Richard J Bloomer

Published in: Nutrition & Metabolism | Issue 1/2012

Login to get access

Abstract

Background

The Daniel Fast is a vegan diet that prohibits the consumption of animal products, refined foods, white flour, preservatives, additives, sweeteners, flavorings, caffeine, and alcohol. Following this dietary plan for 21 days has been demonstrated to improve blood pressure, LDL-C, and certain markers of oxidative stress, but it has also been shown to lower HDL-C. Krill oil supplementation has been shown to increase HDL-C.

Methods

We investigated the effects of following a Daniel Fast dietary plan with either krill oil supplementation (2 g/day) or placebo supplementation (coconut oil; 2 g/day) for 21 days. The subjects in this study (12 men and 27 women) were heterogeneous with respect to body mass index (BMI) (normal weight, overweight, and obese), blood lipids (normolipidemic and hyperlipidemic), blood glucose (normal fasting glucose, impaired fasting glucose, and type 2 diabetic), and blood pressure (normotensive and hypertensive).

Results

Krill oil supplementation had no effect on any outcome measure (all p > 0.05), and so the data from the krill oil group and the placebo group were collapsed and analyzed to examine the effects of following a 21-day Daniel Fast. Significant reductions were observed in LDL-C (100.6 ± 4.3 mg/dL vs. 80.0 ± 3.7 mg/dL), the LDL:HDL ratio (2.0 ± 0.1 vs. 1.7 ± 0.1), fasting blood glucose (101.4 ± 7.5 mg/dL vs. 91.7 ± 3.4 mg/dL), fasting blood insulin (7.92 ± 0.80 μU/mL vs. 5.76 ± 0.59 μU/mL), homeostasis model assessment of insulin resistance (HOMA-IR) (2.06 ± 0.30 vs. 1.40 ± 0.21), systolic BP (110.7 ± 2.2 mm Hg vs. 105.5 ± 1.7 mm Hg), and body weight (74.1 ± 2.4 kg vs. 71.5 ± 2.3 kg) (all p < 0.05).

Conclusion

Following a Daniel Fast dietary plan improves a variety of cardiometabolic parameters in a wide range of individuals in as little as 21 days, and these improvements are unaffected by krill oil supplementation.

Trial registration

Clinicaltrial.govNCT01378767
Literature
1.
go back to reference Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ, American Heart Association Advocacy Coordinating Committee, Stroke Council, Council on Cardiovascular Radiology and Intervention, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular Nursing, Council on the Kidney in Cardiovascular Disease, Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research: Forecasting the future of cardiovascular disease in the United States: a policy statement from the American heart association. Circulation. 2011, 123: 933-944. 10.1161/CIR.0b013e31820a55f5.CrossRef Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ, American Heart Association Advocacy Coordinating Committee, Stroke Council, Council on Cardiovascular Radiology and Intervention, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular Nursing, Council on the Kidney in Cardiovascular Disease, Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research: Forecasting the future of cardiovascular disease in the United States: a policy statement from the American heart association. Circulation. 2011, 123: 933-944. 10.1161/CIR.0b013e31820a55f5.CrossRef
2.
go back to reference Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010, 87: 4-14. 10.1016/j.diabres.2009.10.007.CrossRef Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010, 87: 4-14. 10.1016/j.diabres.2009.10.007.CrossRef
3.
go back to reference Nicholson AS, Sklar M, Barnard ND, Gore S, Sullivan R, Browning S: Toward improved management of NIDDM: a randomized, controlled, pilot intervention using a lowfat, vegetarian diet. Prev Med. 1999, 29: 87-91. 10.1006/pmed.1999.0529.CrossRef Nicholson AS, Sklar M, Barnard ND, Gore S, Sullivan R, Browning S: Toward improved management of NIDDM: a randomized, controlled, pilot intervention using a lowfat, vegetarian diet. Prev Med. 1999, 29: 87-91. 10.1006/pmed.1999.0529.CrossRef
4.
go back to reference Barnard ND, Scialli AR, Turner-McGrievy G, Lanou AJ, Glass J: The effects of a low-fat, plant-based dietary intervention on body weight, metabolism, and insulin sensitivity. Am J Med. 2005, 118: 991-997. 10.1016/j.amjmed.2005.03.039.CrossRef Barnard ND, Scialli AR, Turner-McGrievy G, Lanou AJ, Glass J: The effects of a low-fat, plant-based dietary intervention on body weight, metabolism, and insulin sensitivity. Am J Med. 2005, 118: 991-997. 10.1016/j.amjmed.2005.03.039.CrossRef
5.
go back to reference Barnard ND, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Jaster B, Seidl K, Green AA, Talpers S: A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care. 2006, 29: 1777-1783. 10.2337/dc06-0606.CrossRef Barnard ND, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Jaster B, Seidl K, Green AA, Talpers S: A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care. 2006, 29: 1777-1783. 10.2337/dc06-0606.CrossRef
6.
go back to reference Bloomer RJ, Kabir MM, Canale RE, Trepanowski JF, Marshall KE, Farney TM, Hammond KG: Effect of a 21 day Daniel fast on metabolic and cardiovascular disease risk factors in men and women. Lipids Health Dis. 2010, 9: 94-10.1186/1476-511X-9-94.CrossRef Bloomer RJ, Kabir MM, Canale RE, Trepanowski JF, Marshall KE, Farney TM, Hammond KG: Effect of a 21 day Daniel fast on metabolic and cardiovascular disease risk factors in men and women. Lipids Health Dis. 2010, 9: 94-10.1186/1476-511X-9-94.CrossRef
7.
go back to reference Bloomer RJ, Kabir MM, Trepanowski JF, Canale RE, Farney TM: A 21 day Daniel fast improves selected biomarkers of antioxidant status and oxidative stress in men and women. Nutr Metab (Lond). 2011, 8: 17-10.1186/1743-7075-8-17.CrossRef Bloomer RJ, Kabir MM, Trepanowski JF, Canale RE, Farney TM: A 21 day Daniel fast improves selected biomarkers of antioxidant status and oxidative stress in men and women. Nutr Metab (Lond). 2011, 8: 17-10.1186/1743-7075-8-17.CrossRef
8.
go back to reference Bunea R, El Farrah K, Deutsch L: Evaluation of the effects of Neptune krill oil on the clinical course of hyperlipidemia. Altern Med Rev. 2004, 9: 420-428. Bunea R, El Farrah K, Deutsch L: Evaluation of the effects of Neptune krill oil on the clinical course of hyperlipidemia. Altern Med Rev. 2004, 9: 420-428.
9.
go back to reference Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, Hubacher R, Rains TM: Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res. 2009, 29: 609-615. 10.1016/j.nutres.2009.09.004.CrossRef Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, Hubacher R, Rains TM: Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res. 2009, 29: 609-615. 10.1016/j.nutres.2009.09.004.CrossRef
10.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRef
11.
go back to reference Jentzsch AM, Bachmann H, Furst P, Biesalski HK: Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med. 1996, 20: 251-256. 10.1016/0891-5849(95)02043-8.CrossRef Jentzsch AM, Bachmann H, Furst P, Biesalski HK: Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med. 1996, 20: 251-256. 10.1016/0891-5849(95)02043-8.CrossRef
12.
go back to reference Skarpańska-Stejnborn A, Pilaczyńska-Szcześniak Ł, Basta P, Foriasz J, Arlet J: Effects of supplementation with Neptune krill oil (euphasia superba) on selected redox parameters and pro-inflammatory markers in athletes during exhaustive exercise. J Hum Kinet. 2010, 25: 49-57. 10.2478/v10078-010-0031-4. Skarpańska-Stejnborn A, Pilaczyńska-Szcześniak Ł, Basta P, Foriasz J, Arlet J: Effects of supplementation with Neptune krill oil (euphasia superba) on selected redox parameters and pro-inflammatory markers in athletes during exhaustive exercise. J Hum Kinet. 2010, 25: 49-57. 10.2478/v10078-010-0031-4.
13.
go back to reference Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen JI: Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 2011, 46: 37-46. 10.1007/s11745-010-3490-4.CrossRef Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen JI: Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 2011, 46: 37-46. 10.1007/s11745-010-3490-4.CrossRef
14.
go back to reference Ferdowsian HR, Barnard ND: Effects of plant-based diets on plasma lipids. Am J Cardiol. 2009, 104: 947-956. 10.1016/j.amjcard.2009.05.032.CrossRef Ferdowsian HR, Barnard ND: Effects of plant-based diets on plasma lipids. Am J Cardiol. 2009, 104: 947-956. 10.1016/j.amjcard.2009.05.032.CrossRef
15.
go back to reference Jenkins DJ, Chiavaroli L, Wong JM, Kendall C, Lewis GF, Vidgen E, Connelly PW, Leiter LA, Josse RG, Lamarche B: Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ. 2010, 182: 1961-1967. 10.1503/cmaj.092128.CrossRef Jenkins DJ, Chiavaroli L, Wong JM, Kendall C, Lewis GF, Vidgen E, Connelly PW, Leiter LA, Josse RG, Lamarche B: Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ. 2010, 182: 1961-1967. 10.1503/cmaj.092128.CrossRef
16.
go back to reference Barnard ND, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Green A, Ferdowsian H: A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. Am J Clin Nutr. 2009, 89: 1588S-1596S. 10.3945/ajcn.2009.26736H.CrossRef Barnard ND, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Green A, Ferdowsian H: A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. Am J Clin Nutr. 2009, 89: 1588S-1596S. 10.3945/ajcn.2009.26736H.CrossRef
17.
go back to reference Bian K, Doursout MF, Murad F: Vascular system: role of nitric oxide in cardiovascular diseases. J Clin Hypertens (Greenwich). 2008, 10: 304-310. 10.1111/j.1751-7176.2008.06632.x.CrossRef Bian K, Doursout MF, Murad F: Vascular system: role of nitric oxide in cardiovascular diseases. J Clin Hypertens (Greenwich). 2008, 10: 304-310. 10.1111/j.1751-7176.2008.06632.x.CrossRef
18.
go back to reference Lundberg JO, Carlstrom M, Larsen FJ, Weitzberg E: Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc Res. 2011, 89: 525-532. 10.1093/cvr/cvq325.CrossRef Lundberg JO, Carlstrom M, Larsen FJ, Weitzberg E: Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc Res. 2011, 89: 525-532. 10.1093/cvr/cvq325.CrossRef
Metadata
Title
A 21-day Daniel fast with or without krill oil supplementation improves anthropometric parameters and the cardiometabolic profile in men and women
Authors
John F Trepanowski
Mohammad M Kabir
Rick J Alleman Jr
Richard J Bloomer
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2012
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-9-82

Other articles of this Issue 1/2012

Nutrition & Metabolism 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine